Agendia is a molecular diagnostics company that specializes in cancer testing. The company was founded in 2003 and is headquartered in Aliso Viejo, California. Agendia's tests are designed to help physicians make more informed treatment decisions for cancer patients, based on the unique molecular characteristics of each patient's tumor. The company's flagship product is MammaPrint, a breast cancer test that analyzes the activity of 70 genes to determine a patient's risk of recurrence. Agendia's tests have been validated in numerous clinical studies and are used by physicians around the world.